The US Food and Drug Administration (FDA) has approved ramucirumab (Cyramza, Lilly) as monotherapy for the treatment of patients with hepatocellular carcinoma (HCC) who have an alpha-fetoprotein (AFP) ...
Serum alpha-fetoprotein (AFP) is the current standard of care and only approved biomarker for hepatocellular carcinoma (HCC), used for diagnosis, outcome prediction, long-term follow-up, and treatment ...
First report on the characterization of public and private patients with ovarian cancer in Chile. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a ...
Conventional-dose chemotherapy as first salvage in germ cell tumors: Outcomes from an Ibero-American multi-institutional cohort. This is an ASCO Meeting Abstract from the 2026 ASCO Genitourinary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results